Counterpath (CPAH) Reports Q1 Loss of $0.05/Share

Counterpath (NASDAQ: CPAH) reported Q1 EPS of ($0.05), versus ($0.06) reported last year. Revenue for the quarter came in at $3.1 million, versus $3 million reported last year.

For earnings history and earnings-related data on Counterpath (CPAH) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
• SPAR Group (SGRP) Reports Q2 EPS of $0.04